Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of October 2026
Charlene Vos @Charlene Vos
Platinum member since January 2017

Location: United States

Gender: Female

Asset investment style: Quantitative fundamental analysis

Market capitalization:

$8,224,297talents

Virtual portfolio value:

$5,215,103talents

Net overall return per annum:

18.35%

AYA current rank order:

#11

Asset investment philosophy:
Charlene Vos trades U.S. stocks with the top #26 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 32,466 +2,108.33% $246,417
BQ Boqii Holding Limited American Depositary Shares representing Class A Ordinary Shares $0.36 $3.36 41,969 +833.33% $125,907
BQ Boqii Holding Limited Class A Ordinary Shares $0.36 $3.36 41,969 +833.33% $125,907
UMAC Unusual Machines Inc. Common Stock $1.87 $18.73 7,344 +901.60% $123,820
SXTP 60 Degrees Pharmaceuticals Inc. Common Stock $0.15 $1.34 88,993 +793.33% $105,902
XBIOW Xenetic Biosciences Inc. Warrants $2.00 $23.16 4,611 +1,058.00% $97,569
VATE INNOVATE Corp. Common Stock $0.53 $4.14 25,186 +681.13% $90,921
SSNT SilverSun Technologies Inc. Common Stock $18.59 $130.48 696 +601.88% $77,875
LGVN Longeveron Inc. Class A Common Stock $3.45 $26.25 2,167 +660.87% $49,408
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 1,161 +589.24% $47,682
Sum $1,091,408

Top 10 current stock portfolio positions as of October 2026Strategy

Top 20 influencers

#1 - #5 #6 - #10 #11 - #15 #15 - #20
@Andy Yeh Alpha

Blog+More

Business leaders often think from a systemic perspective, share bold visions, build great teams, and learn new business models.

Becky Berkman

2020-08-05 08:33:00 Wednesday ET

Business leaders often think from a systemic perspective, share bold visions, build great teams, and learn new business models.

Business leaders often think from a systemic perspective, share bold visions, build great teams, and learn new business models. Peter Senge (2006) &nb

+See More

Most major economies grow with great synchronicity several years after the global financial crisis.

John Fourier

2018-01-19 11:32:00 Friday ET

Most major economies grow with great synchronicity several years after the global financial crisis.

Most major economies grow with great synchronicity several years after the global financial crisis. These economies experience high stock market valuation,

+See More

Mark Zuckerberg develops Facebook as a social network platform to help empower global connections among family and friends.

Amy Hamilton

2020-02-12 09:31:00 Wednesday ET

Mark Zuckerberg develops Facebook as a social network platform to help empower global connections among family and friends.

Mark Zuckerberg develops Facebook as a social network platform to help empower global connections among family and friends. David Kirkpatrick (2011) T

+See More

President Donald Trump criticizes Amazon over taxes and jobs.

Monica McNeil

2017-08-19 14:43:00 Saturday ET

President Donald Trump criticizes Amazon over taxes and jobs.

In a recent tweet, President Donald Trump criticizes Amazon over taxes and jobs. Without providing specific evidence, Trump accuses of the e-commerce retail

+See More

Response to USPTO fintech patent protection and accreditation

Andy Yeh Alpha

2023-01-09 10:31:00 Monday ET

Response to USPTO fintech patent protection and accreditation

Response to USPTO fintech patent protection As of early-January 2023, the U.S. Patent and Trademark Office (USPTO) has approved our U.S. utility patent

+See More

The global market for GLP-1 weight-loss medications can grow substantially to benefit more than 1 billion people worldwide by 2030.

Monica McNeil

2025-10-31 12:26:00 Friday ET

The global market for GLP-1 weight-loss medications can grow substantially to benefit more than 1 billion people worldwide by 2030.

With respect to wider weight loss treatment and obesity treatment, the global market for GLP-1 medications now grows substantially to benefit more than 1 bi

+See More